All News

The approval was based on findings from the phase 3 RADIANT-4 trial.

The approval is based on the phase 3 GADOLIN study, in which Gazyva plus bendamustine followed by Gazyva alone reduced the risk of disease progression by 52 percent in patients with follicular lymphoma.

Getting new prostheses can be emotional and challenging, but it doesn't have to be!

One of the greatest challenges we face as cancer survivors is the balancing act between hope and the “reality” of the illness.

My children are intelligent, thoughtful and sensitive. In this case, telling the truth is not always in their best interest.

Jakafi (ruxolitinib) continues to work in this population when taken long-term.

Ed's faith in the hope he had found was becoming stronger throughout his cancer treatment.

A Missouri jury has ordered Johnson & Johnson to pay $72 million in damages to the family of a woman who died from ovarian cancer, which she said was caused by products containing talcum powder.

According to a recent study, many patients with breast cancer are getting sent for unnecessary imaging.

Thanks to a new online tool, oncologists can now better understand and be aware of the prices of the drugs and treatments that they recommend.

More than 50 years after her mother's first diagnosis, Barbara begins to reflect on the many lessons that came from a family member battling oral cancer.

For more than a year, the pain and restricted movement in my jaw are diagnosed as a common joint disorder, but a loss of hearing changes everything.

A two-time cancer survivor several years out from her first diagnosis shares ways to help your cancer survivor “worry brain.”

"The overuse of emergency rooms is driving up health care costs and can hurt the quality of patient care in many ways," said Gregory Masters.

The coming years look promising for advances in treatment of pediatric brain cancer, according to Matthias A. Karajannis.

Hall of Fame quarterback Bob Griese lost his first wife and numerous friends to cancer. Now, he’s using his celebrity to help raise awareness and funds.

The U.S. Food and Drug Administration has approved Ibrance for use in combination with Faslodex in pretreated patients with hormone receptor-positive, HER2-negative metastatic breast cancer.

Ill or not, so many people suffer. But perhaps in sharing that suffering we can change the face of illness, health, suffering and everything in between.

New pathways for secondary-line treatment are coming available to patients with advanced renal cell carcinoma.

Women in their teens and early adulthood may be able to reduce their risk of breast cancer by eating a diet rich in fiber, according to a recent study.

Andrew S. Chi discusses some of the exciting new advancements for treatment of brain cancer.

Fellow cancer survivor Melisa Etheridge's song "I Run for Life" has gained a permanent spot on my running playlist because it reminds me why I run.

Q & A with Naiyer Rizvi on the progression of immunotherapy for non-small cell lung cancer (NSCLC).

At the end of the day, it is the patient who gets to decide what kind of medical treatment is best for them. Doctors may not always like their choice.

Caregivers are not only meaningful and uplifting, but also a necessity for patients.

The FDA has placed a full clinical hold on pacritinib following reports of patient deaths related to intracranial hemorrhage, cardiac failure and cardiac arrest in the phase 3 PERSIST-2 trial.

As Colon Cancer Awareness Month approaches, know your risks for both cancer and Lynch Syndrome, a genetic syndrome that could make you more susceptible to a number of different cancers.

Explaining our cancer to the rest of the world.